Development
Vitro, S.A.B. de C.V.
VITOF
$0.15
-$0.51-77.27%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 7.85% | 14.37% | 18.01% | 20.17% | 16.96% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.85% | 14.37% | 18.01% | 20.17% | 16.96% |
| Cost of Revenue | 3.98% | 8.91% | 14.92% | 18.07% | 17.65% |
| Gross Profit | 21.25% | 34.14% | 28.64% | 27.45% | 14.64% |
| SG&A Expenses | 8.15% | 14.24% | 15.31% | 15.61% | 13.79% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 170.21% | 186.24% | 1,116.41% | -5.65% | -388.71% |
| Total Operating Expenses | 6.58% | 11.22% | 15.45% | 17.50% | 15.22% |
| Operating Income | 33.16% | 100.88% | 89.65% | 113.10% | 67.55% |
| Income Before Tax | 521.74% | 357.39% | 214.03% | 154.56% | 81.82% |
| Income Tax Expenses | -126.09% | -58.03% | -39.48% | 10.32% | 37.28% |
| Earnings from Continuing Operations | 213.16% | 187.51% | 139.64% | 116.26% | 43.79% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 202.26% | 192.99% | 39.20% | 61.62% | -75.05% |
| Net Income | 213.84% | 188.35% | 140.26% | 116.76% | 43.67% |
| EBIT | 33.16% | 100.88% | 89.65% | 113.10% | 67.55% |
| EBITDA | 16.41% | 37.23% | 31.24% | 31.84% | 20.65% |
| EPS Basic | 241.71% | 219.41% | 163.13% | 134.86% | 45.65% |
| Normalized Basic EPS | 205.49% | 294.09% | 608.55% | 1,035.87% | 173.88% |
| EPS Diluted | 241.71% | 219.41% | 163.13% | 134.86% | 45.65% |
| Normalized Diluted EPS | 205.49% | 294.09% | 608.55% | 1,035.87% | 173.88% |
| Average Basic Shares Outstanding | -20.73% | -14.63% | -14.49% | -13.30% | 5.94% |
| Average Diluted Shares Outstanding | -20.73% | -14.63% | -14.49% | -13.30% | 5.94% |
| Dividend Per Share | 200.94% | 200.94% | 200.94% | 200.94% | -41.11% |
| Payout Ratio | 352.35% | 453.84% | 2.47% | 4.52% | 0.99% |